Cargando…
抗人T细胞猪免疫球蛋白联合重组人Ⅱ型肿瘤坏死因子受体-抗体融合蛋白治疗异基因造血干细胞移植后Ⅲ/Ⅳ度急性移植物抗宿主病35例临床研究
OBJECTIVE: To evaluate the efficacy and safety of anti-human T lymphocyte porcine immunoglobulin（P-ATG）with recombinant human tumor necrosis factor-α receptorⅡ:IgG Fc fusion protein（rhTNFR∶Fc，Etanercept）on gradeⅢ/Ⅳ acute graft-versus-host disease（aGVHD）after allogenic hematopoietic stem cell transpl...
| Formato: | Online Artículo Texto |
|---|---|
| Lenguaje: | English |
| Publicado: |
Editorial office of Chinese Journal of Hematology
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7595858/ https://www.ncbi.nlm.nih.gov/pubmed/33113606 http://dx.doi.org/10.3760/cma.j.issn.0253-2727.2020.09.007 |